Pfizer presents ELEVATE pivotal result demonstrating etrasimod's potentially best-n-class profile in ulcerative colitis

Pfizer Inc. announced detailed results from two pivotal studies that make up the ELEVATE UC phase 3 registrational programme evaluating etrasimod, a once-daily, oral, selective sphingosine 1-phosphate (S1P) receptor modulator for the treatment...

Indian vaccine giant Serum Institute plans African plant in worldwide expansion

The Serum Institute of India (SII), the world's largest vaccine maker, is considering setting up its first manufacturing plant in Africa as it looks to expand globally after its success in selling COVID-19 shots, its CEO told Reuters on Monday...

Pfizer & BioNTech say 3 COVID shots elicit good response in children under 5

Drugmakers Pfizer Inc and BioNTech SE said on Monday that three doses of their COVID-19 vaccine generated a strong immune response in children under age 5 and was safe and well-tolerated in their clinical trial...

AstraZeneca's dapagliflozin meets primary endpoint in DELIVER phase III trial

Results from the DELIVER and DAPA-HF phase III trials demonstrate AstraZeneca’s dapagliflozin’ efficacy in heart failure regardless of ejection fraction. It reached a statistically significant and clinically meaningful reduction in the primary...

Akums Drugs receives approval to manufacture Bempedoic acid tablets in India

Akums Drugs & Pharmaceuticals Ltd acquired the license to manufacture and commercialise Bempedoic acid tablet, the drug which is used for treating high LDL-cholesterol conditions that’s indicative of cardiovascular diseases...

Sanofi's Dupixent wins U.S. approval for bigger use

Sanofi won expanded U.S. approval for its best-selling Dupixent injection to treat an allergic inflammation of the esophagus, the Food and Drug Administration said on Friday...

Top 3 Technologies Revolutionizing the Drug Discovery Industry

The development of molecular formulations which become drugs for treating diseases is at the center of the pharmaceutical industry

Prochant confirms Key Partnership with VGM & Associates: HME Industry Update

The 2020s changed the home healthcare industry forever. The Home Medical Equipment (HME) segment of that industry is under more strain than ever. The increase in demand coupled with staffing shortages revealed critical faults in the billing process f

Glenmark Pharmaceuticals receives ANDA authorization for prostate cancer tablets

The United States Food and Drug Administration (USFDA) has granted final approval to Glenmark Pharmaceuticals Inc., USA (Glenmark) for Abiraterone Acetate Tablets...

Biocon Biologics and Viatris launched Abevmy the third oncology biosimilar in Canada

Biocon Biologics, a subsidiary of biopharmaceutical major Biocon and Viatris, an American global healthcare company launched Abevmy (bBevacizumab) , the oncology biosimilar in Canada...

© 2025 India Pharma Outlook. All Rights Reserved.